Is Canagliflozin Doing More Harm Than Good? Experts Weigh In
Want to know is Canagliflozin Doing More Harm Than Good???
Canagliflozin, also known as Invokana, has been a revolutionary discovery in the treatment of patients suffering from type 2 diabetes.
But as with everything in this world, beauty is in the eye of the beholder, and there are always two sides to every story.
Recently there has been an increasing concern that this incredible drug may not be as incredible as we were led to believe.
Let bestdietarysupplementfordiabetics.com do our research, help us have fun while doing it, and give us the facts on this situation.
Article Index:
Introduction
- Overview of Canagliflozin and its role in diabetes management
The Rise of Canagliflozin: A Quick Recap
- Brief history of Canagliflozin (Invokana)
- Introduction to SGLT2 inhibitors
What Makes Canagliflozin So Popular?
- Benefits of Canagliflozin
- Example: John’s success story with Canagliflozin
The Dark Cloud Over Canagliflozin
- Introduction to the controversy surrounding Canagliflozin
The Amputation Risk
- Association with increased risk of lower-limb amputations
- Reference to CANVAS and CANVAS-R clinical trials
Bone Fractures and Bone Density Loss
- Risk of bone fractures and reduction in bone mineral density
- Reference to CANVAS trials
Other Side Effects: The Laundry List
- Overview of additional side effects
Urinary Tract Infections (UTIs)
- Increased risk of UTIs due to Canagliflozin
- Example: Sarah’s experience with UTIs
Dehydration and Electrolyte Imbalance
- Risk of dehydration and related complications
Ketoacidosis
- Explanation of diabetic ketoacidosis (DKA) as a potential side effect
What the Experts Are Saying
- Overview of expert opinions on Canagliflozin
The Supporters
- Arguments in favor of Canagliflozin
- Example: Dr. Susan Thompson’s perspective
The Critics
- Arguments against Canagliflozin
- Example: Dr. Michael Brown’s concerns
Navigating the Risks: What Patients Can Do
- Practical tips for patients using Canagliflozin
Regular Monitoring
- Importance of regular monitoring for side effects
Stay Hydrated
- Tips for staying hydrated while using Canagliflozin
Discuss Concerns with Your Doctor
- Encouragement to communicate with healthcare providers
FAQS on Canagliflozin for Treating Diabetes
Conclusion: Is Canagliflozin Worth the Risk?
The Rise of Canagliflozin: A Quick Recap
Before launching into a diatribe about Canagliflozin’s shortcomings, allow me to bestow some much-deserved kudos upon the drug.
Firstly, Invokana was the first SGLT2 inhibitor to hit the market in 2013.
This medication works by preventing the kidneys from absorbing sugar back into the bloodstream. Rather, the carbohydrates are excreted in the urine.
The drug’s mechanism is similar to GLP-1 agonists, only this time the work is done by the kidneys, not the pancreas. This was the first-ever oral medication for type 2 diabetes that did not require insulin injection.
What Makes Canagliflozin So Popular?
Canagliflozin not only contributed to the hype around it but also provided a significant number of benefits.
The drug was proven to reduce blood sugar levels, which is the prime objective when dealing with diabetes of type 2.
Moreover, it was also found to be efficient in cases concerning weight loss and high blood pressure.
Therefore, for some patients, this was a triple benefit.
John has been suffering from diabetes of type 2 for a long time.
He has tried numerous drugs but none of them worked.
His doctor suggested Canagliflozin and after a while, he saw a significant improvement.
His blood sugar levels decreased and he also lost 10 pounds.
So where is the controversy?
The Dark Cloud Over Canagliflozin
As with all good things, there is often a bad thing associated with them. And as with most of what is good, Canagliflozin is no exception to the rule.
The medication has had its fair share of positive side effects, but there are also some totally frightening things that it can lead to.
The Amputation Risk:
Perhaps the most alarming possible negative side effect of Canagliflozin is the significant increase in risk for lower-limb amputation.
Yes, you read that correctly.
FDA approved the drug after two large-scale clinical trials, CANVAS and CANVAS-R, showed that Canagliflozin users were twice as likely to need an amputation (typically of the toe) as those who didn’t take it .
Imagine going in for a routine medical exam and coming out with a prescription that could potentially cost you a toe. It’s enough to make anyone think twice before their next trip to the doctor.
Bone Fractures and Bone Density Loss:
On a similar note, it’s worth noting that the same CANVAS trials showed that those taking Canagliflozin were also at a significantly increased risk for bone fractures.
The same CANVAS trials that revealed the horrifying amputation risk also demonstrated that canagliflozin users had a significant decrease in bone mineral density at the hip and lower back.
For Jane, a 60-year-old female patient with concerns about osteoporosis, this could be a deal-breaker.
Other Side Effects: The Laundry List
In addition, canagliflozin is linked with side effects that are also disturbing.
Some of them are connected specifically to the mechanism of the drug.
Urinary Tract Infections
Since canagliflozin increases the amount of glucose in a person’s urine, it may lead to a significant rise in UTIs.
For example, Sarah, a 45-year-old teacher, permanently discontinued the drug due to frequent UTIs.
Dehydration and Electrolyte Imbalance
Another adverse effect of canagliflozin is dehydration resulting from an electrolyte imbalance.
Since the drug turns out the glucose in the form of urine, a person may experience light-headedness or even fainting.
It is especially dangerous for elderly people, as dehydration may cause them to have falls and consequent fractures.
For instance, Robert, a 70-year-old retired surgeon, was forced to stop taking the medication due to these side effects.
Ketoacidosis
Moreover, canagliflozin is connected with the development of ketoacidosis.
It occurs when the body breaks down fat at a rapid pace.
As a result, it produces ketone bodies that make the blood too acidic.
This complication was present in some patients who took canagliflozin, even though, in several cases, the level of blood sugar was not extremely high.
What the Experts Are Saying???
With all these risks stacking up, what do the professionals have to say?
Are they still on the side of Canagliflozin or do they finally see the light?
The Supporters:
Many of the healthcare professionals still stand by the drug. They say the benefits definitely outweigh the risks as long as the drug is used correctly.
Doctor Susan Thompson, an endocrinologist, says that Canagliflozin is a very beneficial drug as long as it is given to the correct patient.
“I think it’s important that we make the right choice when administering the drug. Yes, there are side effects to consider, but for patients in need, this drug is a blessing,” she said.
Doctor Thompson also cited a study that shows drugs in the class SGLT-2 inhibitors that Canagliflozin belongs to, reduce the risk of kidney failure and the death of patients with type 2 diabetes .
The Critics:
Meanwhile, some professionals think that the risks of the drug can be much more detrimental than the benefits.
Doctor Michael Brown, a general practitioner, thinks that the side effects of the drug such as amputation and osteoporosis are just too much. “Sometimes, the bad outweighs the good,” he said.
“I’ve seen patients come in complaining about their limbs and joints” continued Dr. Brown, “They were not given the drug, but if they were, would the benefits have been worth the risks? I don’t know. Maybe.”
Navigating the Risks: What Patients Can Do
So, where does this leave the patients?
Well, if you are a patient undergoing Canagliflozin therapy or contemplating it, here are some of the things that you can do to limit the side effects.
Monitoring:
First things first, monitoring is the order of the day.
This means that you should regularly check for signs of damage to the feet as a warning sign of peripheral neuropathy.
You should also do routine body scans to look out for signs of lowered bone density. Not to forget, you should also be on the out for symptoms of UTIs and dehydration.
These are all warning signs that something is going wrong in the body and needs to be addressed.
Drinking More Water:
Since Canagliflozin often leads to dehydration, it is important to ensure that you are sufficiently hydrated.
This is why you should always try to drink more water, especially when you are on the medication. It is also important to look out for symptoms of dehydration.
If these symptoms arise, you should speak to your doctor and ask what the best course of action is.
Speaking to the Doctor:
It is important to speak to your doctor about your fears regarding the medication.
In some cases, the doctor might recommend doing away with Canagliflozin and switching to an alternative drug.
The decision to switch or not will be based on the pros and cons of each drug in relation to the patient’s condition.
FAQS on Canagliflozin for Treating Diabetes:
Q-1. Can the drug canagliflozin help your heart and kidneys even if your blood-sugar levels are only slightly reduced?
A-1: Yes, the drug canagliflozin belongs to a class of drugs known as SGLT2 inhibitors. This drug reduces sugar levels in the blood since it increases urinary glucose excretion; however, this drug can also provide cardiovascular and renal benefits to individuals with type 2 diabetes.
Q-2. Why does the drug canagliflozin cause the kidneys to rid the body of sugar instead of making the body produce more insulin?
A-2: This drug inhibits the SGLT2 protein in the kidney and decreases glucose reabsorption; thus, increasing the amount of glucose that is excreted in the urine. Unlike other anti-diabetic drugs, canagliflozin does not cause the body to make more insulin.
Q-3. Does the effectiveness of canagliflozin in reducing blood-glucose levels diminish as the kidney function declines?
A-3: Yes, the effectiveness of canagliflozin in reducing blood-glucose levels decreases as the renal function declines; however, since this drug offers cardiovascular and renal benefits, it is indicated for certain patients with chronic kidney disease and type 2 diabetes.
Q-4. What makes a diabetes drug that causes more sugar to be excreted in the urine also cause dehydration?
A-4: Since this drug causes the kidneys to excrete more glucose in the urine, and glucose in the urine may cause the person to be dehydrated, this drug may also cause hypotension, dizziness, and dehydration.
Q-5. How come the drug canagliflozin does lower blood-sugar levels, but it does not automatically cause low blood-sugar levels in almost everyone?
A-5: The drug canagliflozin has a low risk of causing hypoglycemia; however, if it is administered together with insulin or with anti-diabetic drugs that stimulate insulin production, then the risk of hypoglycemia increases.
Q-6. Is there any possibility that a successful treatment using canagliflozin may turn out to be a disaster because the patient’s glucose meters do not indicate dangerous levels?
A-6: Yes, one of the serious adverse effects of these drugs is diabetic ketoacidosis. The presence of diabetic ketoacidosis can occur even when blood glucose levels are normal or only mildly elevated, and it often develops when patients are undergoing long periods of fasting, severe illnesses, surgeries, and severe dehydration.
Q-7. Why does the drug canagliflozin cause frequent urination even though it is indicated for the treatment of diabetes?
A-7: The drug canagliflozin is designed to increase glucose excretion through the urine; thus, it can cause more frequent urination. In addition, this drug can also cause dehydration, which can also contribute to frequent urination.
Q-8. Is it possible for the patient to actually lose weight as a result of taking canagliflozin?
A-8: Yes, since this drug causes glucose loss in the urine, it can cause weight loss as a result of calorie deficiency. However, this drug was not designed to cause weight loss; instead, it is mainly used to treat type 2 diabetes.
Q-9. Why should someone who is taking canagliflozin tell his or her doctor before undergoing major surgeries?
A-9: Undergoing surgeries and procedures that involve a significant period of fasting can cause SGLT2-associated ketoacidosis. Therefore, the manufacturer recommends discontinuing the administration of canagliflozin at least 3 days before undergoing surgery or procedures that require the patient to fast for a long period of time.
Q-10. Is canagliflozin only prescribed to control one’s blood-sugar levels or is it a new approach to treating diabetes?
A-10: Canagliflozin is not only used to control blood-sugar levels; instead, it is a modern approach to treating diabetes since it helps minimize the occurrence of some complications that are related to diabetes. It is important to note that the decision to prescribe this drug depends on the patient’s condition and the presence of other risk factors.
Takeaway
The matter of Canagliflozin being more harmful than beneficial is not black and white.
For some people, the medication has been nothing but a blessing, helping them achieve lower glucose levels, shed pounds, and even lower cholesterol levels in the process (which helps people with type 2 diabetes).
However, for other individuals, the possible side effects, including amputation and fractures, may be too severe.
According to bestdietarysupplementfordiabetics.com, “patients should make the choice to take Canagliflozin on an individual basis, while taking into account the potential benefits and the potential risks”.
Therefore, it is imperative to have an honest conversation with your doctor before making this choice.
After all, Canagliflozin is a blessing and a curse wrapped in one – it ultimately depends on the individual.
So, if you are a current or potential user of Canagliflozin, do not forget to consult your doctor and pay heed to your body. Ideally, you should combine the medication with the best supplements to lower blood sugar.
References:
